FindTrial
Sign In

Intermediate-term results of transcatheter device closure of PFO for with embolic stroke of undetermined sources (ESUS)

Intermediate-term results of transcatheter device closure of PFO for with embolic stroke of undetermined sources(ESUS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20200512001
Enrollment
80
Registered
2020-05-12
Start date
2018-05-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke or TIA stroke or TIA

Interventions

Patients who underwent transcatheter closure of PFO
Prevention
Transcatheter closure of PFO

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent transcatheter closure of PFO with indication as ESUS or TIA. embolic stroke of undetermined sources (ESUS) is a diagnosis based on visualized non-lacunar infarct with clearly defined diagnostic assessments to exclude proximal occlusive atherosclerosis or major-risk embolic sources. 2.Patients who underwent transcatheter closure of PFO with indication as platypnea-orthodeoxia syndrome / hypoxia, orthodeoxy. 3.Patients who underwent transcatheter closure of PFO with other indication

Exclusion criteria

Exclusion criteria: 1. Patients who underwent transcatheter closure of ASD

Design outcomes

Primary

MeasureTime frame
Recurrent stroke % per patient year follow up % per patient year follow up ,Recurrent stroke % per patient year follow up % per patient year follow up—

Secondary

MeasureTime frame
residual shunt % per patient year follow up % of residuaal shunt—

Countries

Thailand

Contacts

Public ContactKritvikrom Durongpisitkul

Siriraj Hospital

kritvikrom.dur@mahidol.ac.th66819875334

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026